Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer

NCT00390806 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

472

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer, Non-Small Cell

Interventions

DRUG: HYCAMTIN, oral capsules
RADIATION: Radiation

Sponsor

GlaxoSmithKline